Use of liraglutide 3mg daily in patients with obesity without diabetes was associated with nausea in 40.2% compared to 14.7% in the placebo (68)
Medical distributors and wholesalers can benefit from its use in energy enhancement, cardiovascular health support, fatigue management, and performance improvement
[16] [17] GLP-1 receptor agonists are not recommended during pregnancy or breastfeeding
A major analysis published earlier this year based on health data from more than two million Americans veterans with diabetes found that, compared to more traditional drugs, GLP-1 use was associated with a reduced risk of substance use (alcohol, cannabis, stimulants and opioids), psychotic disorders such as schizophrenia, seizures, several respiratory conditions and neurocognitive diseases like Alzheimers and dementia
Taking creatine with a normal meal is sufficient
Its common to hit a plateau after 6 months on semaglutide